3,470
Views
3
CrossRef citations to date
0
Altmetric
Review

Ocular Surface Disease and Anti-Glaucoma Medications: Various features, Diagnosis, and Management Guidelines

&
Pages 158-166 | Received 07 Mar 2022, Accepted 08 Mar 2022, Published online: 01 Aug 2022

Figures & data

Table 1. Table showing summary of adverse effects of various AGMs.

Figure 1. Periocular dermatitis and blepharitis with skin excoriation (a) and lichenification (b).

Figure 1. Periocular dermatitis and blepharitis with skin excoriation (a) and lichenification (b).

Figure 2. Lid changes in the form of entropion (a), lid margin keratinization (b), and punctal stenosis (c).

Figure 2. Lid changes in the form of entropion (a), lid margin keratinization (b), and punctal stenosis (c).

Figure 3. The conjunctival changes showing chemosis and follicular reaction in the bulbar conjunctiva (a), a lacy follicular reaction in the tarsal conjunctiva (b), subconjunctival fibrosis of the palpebral conjunctiva (c), forniceal shortening (d), and symblepharon formation (e).

Figure 3. The conjunctival changes showing chemosis and follicular reaction in the bulbar conjunctiva (a), a lacy follicular reaction in the tarsal conjunctiva (b), subconjunctival fibrosis of the palpebral conjunctiva (c), forniceal shortening (d), and symblepharon formation (e).

Figure 4. The corneal changes showing superficial punctate keratitis (a), corneal opacification, and vascularization (b), sterile corneal melt (c).

Figure 4. The corneal changes showing superficial punctate keratitis (a), corneal opacification, and vascularization (b), sterile corneal melt (c).

Figure 5. (a) A patient with antiglaucoma medication toxicity showing conjunctival congestion, discharge, and peripheral corneal vascularization, (b and c) Showing quiet eyes of the same patient with quiet ocular surface post combined cataract and trabeculectomy surgery and stopping all topical medications.

Figure 5. (a) A patient with antiglaucoma medication toxicity showing conjunctival congestion, discharge, and peripheral corneal vascularization, (b and c) Showing quiet eyes of the same patient with quiet ocular surface post combined cataract and trabeculectomy surgery and stopping all topical medications.